HIV and smoking: Associated risks and prevention strategies

Wanjiku Kariuki, Jennifer I. Manuel, Ngaruiya Kariuki, Ellen Tuchman, Johnnie O’Neal, Genevieve A. Lalanne

    Research output: Contribution to journalReview article

    Abstract

    High rates of smoking among persons living with HIV (PLWH) may reduce the effectiveness of HIV treatment and contribute to significant morbidity and mortality. Factors associated with smoking in PLWH include mental health comorbidity, alcohol and drug use, health-related quality of life, smoking among social networks and supports, and lack of access to care. PLWH smokers are at a higher risk of numerous HIV-associated infections and non-HIV related morbidity, including a decreased response to antiretroviral treatment, impaired immune functioning, reduced cognitive functioning, decreased lung functioning, and cardiovascular disease. Seventeen smoking cessation interventions were identified, of which seven were randomized controlled trials. The most effective studies combined behavioral and pharmacotherapy treatments that incorporated comprehensive assessments, multiple sessions, and cognitive-behavioral and motivational strategies. Smoking cessation interventions that are tailored to the unique needs of diverse samples and incorporate strategies to reduce the risk of relapse are essential to advancing health outcomes in PLWH.

    Original languageEnglish (US)
    Pages (from-to)17-36
    Number of pages20
    JournalHIV/AIDS - Research and Palliative Care
    Volume8
    DOIs
    StatePublished - Dec 24 2015

    Fingerprint

    Smoking
    HIV
    Smoking Cessation
    Social Support
    Morbidity
    Lung Diseases
    HIV Infections
    Comorbidity
    Mental Health
    Cardiovascular Diseases
    Randomized Controlled Trials
    Alcohols
    Quality of Life
    Recurrence
    Drug Therapy
    Mortality
    Health
    Therapeutics
    Pharmaceutical Preparations

    Keywords

    • AIDS
    • Health risks
    • HIV
    • Smoking
    • Smoking cessation interventions

    ASJC Scopus subject areas

    • Epidemiology
    • Health Policy
    • Dermatology
    • Infectious Diseases
    • Virology

    Cite this

    Kariuki, W., Manuel, J. I., Kariuki, N., Tuchman, E., O’Neal, J., & Lalanne, G. A. (2015). HIV and smoking: Associated risks and prevention strategies. HIV/AIDS - Research and Palliative Care, 8, 17-36. https://doi.org/10.2147/HIV.S56952

    HIV and smoking : Associated risks and prevention strategies. / Kariuki, Wanjiku; Manuel, Jennifer I.; Kariuki, Ngaruiya; Tuchman, Ellen; O’Neal, Johnnie; Lalanne, Genevieve A.

    In: HIV/AIDS - Research and Palliative Care, Vol. 8, 24.12.2015, p. 17-36.

    Research output: Contribution to journalReview article

    Kariuki, W, Manuel, JI, Kariuki, N, Tuchman, E, O’Neal, J & Lalanne, GA 2015, 'HIV and smoking: Associated risks and prevention strategies', HIV/AIDS - Research and Palliative Care, vol. 8, pp. 17-36. https://doi.org/10.2147/HIV.S56952
    Kariuki W, Manuel JI, Kariuki N, Tuchman E, O’Neal J, Lalanne GA. HIV and smoking: Associated risks and prevention strategies. HIV/AIDS - Research and Palliative Care. 2015 Dec 24;8:17-36. https://doi.org/10.2147/HIV.S56952
    Kariuki, Wanjiku ; Manuel, Jennifer I. ; Kariuki, Ngaruiya ; Tuchman, Ellen ; O’Neal, Johnnie ; Lalanne, Genevieve A. / HIV and smoking : Associated risks and prevention strategies. In: HIV/AIDS - Research and Palliative Care. 2015 ; Vol. 8. pp. 17-36.
    @article{4abe9baf5fd3479bb910fa3fd4d8a0ac,
    title = "HIV and smoking: Associated risks and prevention strategies",
    abstract = "High rates of smoking among persons living with HIV (PLWH) may reduce the effectiveness of HIV treatment and contribute to significant morbidity and mortality. Factors associated with smoking in PLWH include mental health comorbidity, alcohol and drug use, health-related quality of life, smoking among social networks and supports, and lack of access to care. PLWH smokers are at a higher risk of numerous HIV-associated infections and non-HIV related morbidity, including a decreased response to antiretroviral treatment, impaired immune functioning, reduced cognitive functioning, decreased lung functioning, and cardiovascular disease. Seventeen smoking cessation interventions were identified, of which seven were randomized controlled trials. The most effective studies combined behavioral and pharmacotherapy treatments that incorporated comprehensive assessments, multiple sessions, and cognitive-behavioral and motivational strategies. Smoking cessation interventions that are tailored to the unique needs of diverse samples and incorporate strategies to reduce the risk of relapse are essential to advancing health outcomes in PLWH.",
    keywords = "AIDS, Health risks, HIV, Smoking, Smoking cessation interventions",
    author = "Wanjiku Kariuki and Manuel, {Jennifer I.} and Ngaruiya Kariuki and Ellen Tuchman and Johnnie O’Neal and Lalanne, {Genevieve A.}",
    year = "2015",
    month = "12",
    day = "24",
    doi = "10.2147/HIV.S56952",
    language = "English (US)",
    volume = "8",
    pages = "17--36",
    journal = "HIV/AIDS - Research and Palliative Care",
    issn = "1179-1373",
    publisher = "Dove Medical Press Ltd.",

    }

    TY - JOUR

    T1 - HIV and smoking

    T2 - Associated risks and prevention strategies

    AU - Kariuki, Wanjiku

    AU - Manuel, Jennifer I.

    AU - Kariuki, Ngaruiya

    AU - Tuchman, Ellen

    AU - O’Neal, Johnnie

    AU - Lalanne, Genevieve A.

    PY - 2015/12/24

    Y1 - 2015/12/24

    N2 - High rates of smoking among persons living with HIV (PLWH) may reduce the effectiveness of HIV treatment and contribute to significant morbidity and mortality. Factors associated with smoking in PLWH include mental health comorbidity, alcohol and drug use, health-related quality of life, smoking among social networks and supports, and lack of access to care. PLWH smokers are at a higher risk of numerous HIV-associated infections and non-HIV related morbidity, including a decreased response to antiretroviral treatment, impaired immune functioning, reduced cognitive functioning, decreased lung functioning, and cardiovascular disease. Seventeen smoking cessation interventions were identified, of which seven were randomized controlled trials. The most effective studies combined behavioral and pharmacotherapy treatments that incorporated comprehensive assessments, multiple sessions, and cognitive-behavioral and motivational strategies. Smoking cessation interventions that are tailored to the unique needs of diverse samples and incorporate strategies to reduce the risk of relapse are essential to advancing health outcomes in PLWH.

    AB - High rates of smoking among persons living with HIV (PLWH) may reduce the effectiveness of HIV treatment and contribute to significant morbidity and mortality. Factors associated with smoking in PLWH include mental health comorbidity, alcohol and drug use, health-related quality of life, smoking among social networks and supports, and lack of access to care. PLWH smokers are at a higher risk of numerous HIV-associated infections and non-HIV related morbidity, including a decreased response to antiretroviral treatment, impaired immune functioning, reduced cognitive functioning, decreased lung functioning, and cardiovascular disease. Seventeen smoking cessation interventions were identified, of which seven were randomized controlled trials. The most effective studies combined behavioral and pharmacotherapy treatments that incorporated comprehensive assessments, multiple sessions, and cognitive-behavioral and motivational strategies. Smoking cessation interventions that are tailored to the unique needs of diverse samples and incorporate strategies to reduce the risk of relapse are essential to advancing health outcomes in PLWH.

    KW - AIDS

    KW - Health risks

    KW - HIV

    KW - Smoking

    KW - Smoking cessation interventions

    UR - http://www.scopus.com/inward/record.url?scp=84953249867&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84953249867&partnerID=8YFLogxK

    U2 - 10.2147/HIV.S56952

    DO - 10.2147/HIV.S56952

    M3 - Review article

    AN - SCOPUS:84953249867

    VL - 8

    SP - 17

    EP - 36

    JO - HIV/AIDS - Research and Palliative Care

    JF - HIV/AIDS - Research and Palliative Care

    SN - 1179-1373

    ER -